Your browser doesn't support javascript.
loading
Impact of Age of Heart Transplant Program on Patient Survival and Post-Transplant Outcomes.
Majure, David T; Sayer, Gabriel; Clerkin, Kevin J; Karas, Maria G; Jones, Mandisa; Horn, Evelyn M; Naka, Yoshifumi; Uriel, Nir.
Afiliación
  • Majure DT; Department of Medicine, Division of Cardiology, Weill Cornell Medical College, New York, USA.
  • Sayer G; Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians, and Surgeons, New York, USA.
  • Clerkin KJ; Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians, and Surgeons, New York, USA.
  • Karas MG; Department of Medicine, Division of Cardiology, Weill Cornell Medical College, New York, USA.
  • Jones M; Department of Anesthesiology, Weill Cornell Medical College, New York, USA.
  • Horn EM; Department of Medicine, Division of Cardiology, Weill Cornell Medical College, New York, USA.
  • Naka Y; Department of Cardiothoracic Surgery, Weill Cornell Medical College, New York, USA.
  • Uriel N; Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians, and Surgeons, New York, USA.
Clin Transplant ; 38(7): e15387, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38952190
ABSTRACT

BACKGROUND:

The relationship between age of a heart transplant (HT) program and outcomes has not been explored.

METHODS:

We performed a retrospective cohort analysis of the United Network for Organ Sharing database of all adult HTs between 2009 and 2019. For each patient, we created a variable that corresponded to program age new (<5), developing (≥5 but <10) and established (≥10) years.

RESULTS:

Of 20 997 HTs, 822 were at new, 908 at developing, and 19 267 at established programs. Patients at new programs were significantly more likely to have history of cigarette smoking, ischemic cardiomyopathy, and prior sternotomy. These programs were less likely to accept organs from older donors and those with a history of hypertension or cigarette use. As compared to patients at new programs, transplant patients at established programs had less frequent rates of treated rejection during the index hospitalization (HR 0.43 [95% CI, 0.36-0.53] p < 0.001) and at 1 year (HR 0.58 [95% CI, 0.49-0.70], p < 0.001), less frequently required pacemaker implantations (HR 0.50 [95% CI, 0.36-0.69], p < 0.001), and less frequently required dialysis (HR 0.66 [95% CI, 0.53-0.82], p < 0.001). However, there were no significant differences in short- or long-term survival between the groups (log-rank p = 0.24).

CONCLUSION:

Patient and donor selection differed between new, developing, and established HT programs but had equivalent survival. New programs had increased likelihood of treated rejection, pacemaker implantation, and need for dialysis. Standardized post-transplant practices may help to minimize this variation and ensure optimal outcomes for all patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Corazón Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Corazón Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos